Serologic evidences suggesting the presence of Borrelia burgdorferi infection in Mexico

Archives of Medical Research

Volumn 30, Issue 1, 1999, Pages 64-68

  Gordillo, Guadalupe ^a   Torres, Javier ^b   Solorzano, Fortino ^a   Cedillo Rivera, Roberto ^b   Tapia Conyer, Roberto ^c   Muñoz, Onofre ^b  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

Author keywords

Borrelia burgdorferi; Epidemiology; Lyme disease; Mexico; Serology

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; BORRELIA BURGDORFERI; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYME DISEASE; MALE; MEXICO; NORMAL HUMAN; SEROLOGY; SEROPREVALENCE; SERUM; SOCIOECONOMICS; TICK BORNE DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BORRELIA BURGDORFERI GROUP; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEYS; HUMANS; IMMUNOGLOBULIN G; INFANT; LYME DISEASE; MALE; MEXICO; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 0032982668     PISSN: 01880128     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-0128(98)00015-3     Document Type: Article

References (24)

1. Steere A.C., Grodzicky R.L., Malawista S.E.et al. The spirochetal etiology of Lyme disease. N Engl J Med. 308:1983;733.
2. Walter P.H., Wilske B., Weber K. Lyme borreliosis: Basic science and clinical aspect. Lancet. 343:1994;1013.
3. Fahrer H., Van der L.S.M., Sauvain M.J., Gern L., Zhioua E., Aeschliman A. The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J Infect Dis. 163:1991;305.
4. Rath P.M., Ibershoff B., Mohnhaupt A.et al. Seroprevalence of Lyme borreliosis in forestry workers from Brandenburg, Germany. Eur J Clin Microbiol Infect Dis. 15:1996;372.
5. Cooper C., Muhlemann M.F., Wright D.J.M., Hutchinson C.A., Armstrong R., Mainin R.N. Arthritis as manifestation of Lyme disease in England. Lancet. 1:1987;1313.
6. Hanrahan J.P., Benach J.L., Coleman J.L.et al. Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis. 150:1984;489.
7. Steere A.C., Malawista L.A.et al. Cases of Lyme disease in the United States. locations correlated with distribution of Ixodes dammini Ann Int Med. 91:1979;730.
8. Steere A.C., Taylor E., Wilson M.L., Levine J.F., Spielman A. Longitudinal assessment of clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis. 154:1986;295.
9. Woodham C.B., González O.A., López L.A., Güereña M.R. Progresos en la erradicación de las garrapatas Boofhilus en México 1960-1980. Rev Mundial Zootecnia. 48:1983;18.
10. ra. ed; 1982;126:71.
11. Maradiaga C.M.A., Llausás V.A., Baguera H.J.et al. Eritema crónico migratorio asociado a artritis. Enfermedad de Lyme o una variante. Rev Mex Reumatol. 61:1991;1.
12. Arroyave C.M., Tomez G.R. Enfermedad de Lyme. Informe de casos. Bol Med Hosp Infant Mex. 51:1994;117.
13. Magos L.C., Sánchez V.F., Gutiérrez G., Tapia C.R. Banco Nacional de Sueros. Salud Pública. 34:1992;136.
14. Rusell H., Sampson J.S., Schmid G.P., Wilkinson H.W., Plikaytis B. Enzyme-linked immunosorbent assay for Lyme disease. J Infect Dis. 149:1984;465.
15. Dressler F., Whelan J.A., Reinhart B.N., Steere A.C. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 167:1993;392.
16. Johnson B.J.B., Robbins K.E., Dennis D.T.et al. Serodiagnosis of Lyme disease. accuracy of a two step approach using a flagella based ELISA and immunoblotting J Infect Dis. 174:1996;346.
17. Hilton E., Devoti J., Sood S. Recommendation to include OspA and Osp B in the new immunoblotting criteria for serodiagnosis of Lyme disease. J Clin Microbiol. 34:1995;1353.
18. st National Scientific Meeting, Washington, D.C., 1997.
19. Hauser U., Lehnert G., Lobentanzer R., Wilske B. Interpretation criteria for standardized Western blot for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol. 35:1997;1433.
20. Norman G.L., Antig J.M., Bigaignon G., Hogrefe W. Serodiagnosis of Lyme Borreliosis by Borrelia burgdorferi Sensu stricto, B. garinni, and B. afzelii Western blots (immunoblots). J Clin Microbiol. 34:1996;1732.
21. Centers for Disease Control and Prevention. Recommendations for Test Performance and Interpretation from the Second National Conference on Serological Diagnosis of Lyme Disease. MMWR 1995;44:590.
22. Campbell G.L., Mitchell P.D., Persing D.H. Genetic heterogeneity of Borrelia burgdorferi in the Unites States. J Infect Dis. 175:1997;98.
23. Magnarelli L.A., Miller J.N., Anderson J.F., Riviere G.R. Cross-reactivity of nonspecific treponema antibody in serologic tests for Lyme disease. J Clin Microbiol. 28:1990;1276.
24. Bunikis J., Noppa L., Ostberg Y., Barbour A.G., Bergstrom S. Surface exposure and species specificity of an immunoreactive domain of a 66-kiloDalton outer membrane protein (p66) of the Borrelia spp. that cause Lyme disease. Infect Immun. 64:1996;5111.